Market capitalization | €20.13m |
Enterprise Value | €20.57m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 1.15 |
P/S ratio (TTM) P/S ratio | 1.13 |
P/B ratio (TTM) P/B ratio | 0.95 |
Dividend yield | 2.69% |
Last dividend (FY23) | €0.10 |
As a Free StocksGuide user, you can view scores for all 6,879 stocks worldwide.
1 Analyst has issued a forecast Geratherm Medical:
1 Analyst has issued a forecast Geratherm Medical:
Jun '24 |
+/-
%
|
||
Revenue | 18 18 |
26%
26%
|
|
Gross Profit | 3.38 3.38 |
36%
36%
|
|
EBITDA | 2.02 2.02 |
4%
4%
|
EBIT (Operating Income) EBIT | 0.12 0.12 |
46%
46%
|
Net Profit | -0.83 -0.83 |
1,975%
1,975%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Geratherm Medical AG engages in the manufacturing and distribution of medical technology products used for temperature management and medical diagnostics. It operates through the following business segments: Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke, and Respiratory. The Healthcare Diagnostic segment manufactures and supplies clinical thermometers, blood pressure monitors, and women's health products. The Medical Warming Systems segment sells incubators and warming systems used for surgeries and emergency responses. The Cardio/Stroke segment offers medical technology products that are designed to prevent strokes. The Respiratory segment develops, produces, and sells products used in pulmonary function and cardiopulmonary exercise testing. The company was founded in 1990 and is headquartered in Geschwenda, Germany.
Head office | Germany |
CEO | Christian Frick |
Founded | 1990 |
Website | www.geratherm.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.